Autolus Therapeutics plc (Nasdaq: AUTL), a commercial stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, today announced that the ...

Analysts have recently trimmed their price targets on Autolus Therapeutics by about $2 to $3 per share, while the model fair value estimate remains at $8.81 per share. Some interpret these lower ...

Autolus Therapeutics plc (NASDAQ:AUTL) is one of the best biotech penny stocks to buy in 2026. On March 27, Autolus ...

Initiative focused on driving gross profit margin and path to profitability for the ALL businessCompany will reduce headcount by approximately ...

Cell therapy developer Autolus has a lead program under FDA review for a type of blood cancer and in clinical development for other indications. As the company looks ahead to a potential product ...

Autolus Therapeutics is cutting about 13% of its workforce across all areas of the business.

Autolus Therapeutics is almost ready to make a late play for the CD19 CAR-T cell therapy space. The biotech now has phase 2 data showing its asset hit the primary endpoint at an interim analysis and ...

Autolus Therapeutics (NASDAQ:AUTL) is gearing up to announce its quarterly earnings on Wednesday, 2025-11-12. Here's a quick overview of what investors should know before the release. Analysts are ...

In this article, we will discuss the 9 Best Biotech Penny Stocks to Buy in 2026. On April 24, Drew Pettit, Citi US equity ...

Shares of Autolus Therapeutics (NASDAQ: AUTL) were crashing 35.9% as of 10:34 a.m. ET on Friday. The steep decline came after the biopharmaceutical company announced the price of a public stock ...

Autolus Therapeutics plc is a UK-based biotech that has brought its ex-vivo CAR-T cell therapy to market in B-ALL with a "best-in-class" safety/efficacy profile. In this small indication, peak ...

Autolus plans to sell 75 million American depositary shares at a price of $2 each. The proceeds will be used to fund the development of the company's obe-cell cancer cell therapy. Autolus said that it ...